Opportunities for genomic drug discovery.

The Tohoku Medical Megabank, a national treasure of biotechnology in our country, has completed genome reading of 100,000 residents. It announced that it will release the data in early autumn and at the same time proceed with easing access. The infrastructure for genome drug discovery has been developed. Pharmaceutical companies and biotechnology should take up the challenge of utilising it.
https://miyata-bio.net/column/0000338/

Translated with DeepL.com (free version)